Page 12 of 13
PharmaJet featured in global health innovator, PATH’s newsletter
To help end polio, intradermal delivery takes center stage.
June 30, 2016
Safety and immunogenicity of inactivated poliovirus vaccine when given with measles–rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia
2016 Clarke, E
Tags: Inactivated, Phase 1/2, Polio, Stratis, Tropis, Tropis/Stratis
June 27, 2016
Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates
2016 Strouts, FR
Tags: Arboviruses, Dengue, Live Attenuated, Non-Human Primate, Stratis, Tropis, Tropis/Stratis
May 23, 2016
Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: Association between injection quality and immunogenicity
2013 Resik, S
Tags: Inactivated, Phase 3/4, Polio, Tropis
October 26, 2015
PharmaJet featured in US News and World Report
4 Options for Patients Afraid of Needles
June 11, 2015
PharmaJet Featured in InnovatioNews
PharmaJet: Consumers express high satisfaction with needle-free flu shots
March 9, 2015
Immunogenicity and safety of measles–mumps–rubella vaccine delivered by disposable-syringe jet injector in healthy Brazilian infants: A randomized non-inferiority study
2013 de Menezes Martins, R
Tags: Live Attenuated, MMR, Other Viruses, Stratis
March 1, 2015
Health Care Providers Report Ease of Use, and Preference for the PharmaJet Needle-Free Injector
GOLDEN, Colo. – March 17, 2015 – PharmaJet, the maker of innovative needle-free technology, today announced survey data revealing that healthcare providers (HCPs) would recommend the needle-free injector to colleagues and believed that the use of such a device had the capacity to increase vaccination compliance.
February 19, 2015
Survey Reveals Consumer Preference for the PharmaJet Needle-Free Flu Shot
GOLDEN, Colo. – February 26, 2015– Today, PharmaJet, the maker of innovative, needle-free injector technology, announced the release of survey data demonstrating consumer satisfaction with the PharmaJet Needle-Free Injector for seasonal flu vaccinations.
Patient Preference Survey – Stratis
Early in the 2014-2015 flu season, nearly 1,500 patients received a flu shot with the PharmaJet Needle-Free Injector at select retail pharmacies, a university flu shot event, a public health flu symposium, and a government research organization.
February 13, 2015
Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: A randomized controlled trial in Cuba
2013 Resik, S
Tags: Inactivated, Polio, Tropis
January 3, 2015
Clinical Findings Published in The Lancet Support Administration of Flu Vaccine with PharmaJet’s Needle-Free Injector
GOLDEN, Colo. – September 30, 2014 – A clinical study published in the August 23, 2014 issue of The Lancet demonstrated that delivery of AFLURIA® (Influenza Vaccine) with the PharmaJet Needle-Free Injector compared favorably to traditional needle and syringe delivery. The U.S. Food and Drug Administration (FDA) recently approved the Stratis® 0.5mL Needle-Free Jet Injector…
September 8, 2014
PharmaJet Featured In InnovatioNews
PharmaJet gets first FDA approval to use needle-free injection technology for flu shots
August 20, 2014
FDA Approves Use of Afluria®, Influenza Vaccine with PharmaJet’s Needle-Free Injector
KING OF PRUSSIA, Penn. / GOLDEN, Colo. – August 19, 2014 – PharmaJet® Inc., the developer of a needle-free injection technology to administer medications and vaccines to patients, and bioCSL Inc., the maker of AFLURIA® (Influenza Vaccine) today announced the U.S. Food and Drug Administration (FDA) has approved the PharmaJet Stratis® 0.5mL Needle-Free Jet Injector…
August 18, 2014
Needle-free jet injection for administration of influenza vaccine: a randomised non-inferiority trial
2014 McAllister, L
Tags: Inactivated, Influenza, Phase 4, Respiratory Viruses, Stratis
August 3, 2014
A rapid immunization strategy with a live-attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates
2014 Ambuel, Y
Tags: Arboviruses, Dengue, Live Attenuated, Non-Human Primate, Stratis, Tropis, Tropis/Stratis
June 5, 2014
A Hantavirus Pulmonary Syndrome (HPS) DNA Vaccine Delivered Using a Spring-powered Jet Injector Elicits a Potent Neutralizing Antibody Response in Rabbits and Nonhuman Primates
2014 Kwilas, S https://www.sciencedirect.com/science/article/pii/S0264410X21007064?via%3Dihub
Tags: ANDV, DNA, Hantaviruses, Improved Performance, Non-Human Primate, Rabbit, SNV, Stratis, Tropis, Tropis/Stratis
June 1, 2014
Page 12 of 13